Cittelly et al. showed that Klf4 was overexpressed in CD44-positive MCF-7 and T47D breast cancer cells, and downregulation of siRNA or miR-29 targeting Klf4 led to a decrease in the number of these cells (Cittelly et al., 2013). Here, KLF4 is linked to breast carcinoma.